// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Drug survival and efficacy of abatacept in rheumatoid arthritis patients in routine care – 7 year experience from a single centre in the united kingdom

N. Nolkha - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Abatacept

Dynamic contrast enhanced (DCE-mri in relation to inflammatory markers in serum and joint fluid: initial data and validation in four most common knee arthritic diseases

M. Boesen - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Dysregulation of nf-Κb in glandular epithelial cells results in sjÖgren’s-like features

X. Wang - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Pilocarpine

Early arthritis service is cost effective, improves outcomes and reduces biologic use

G.A. Niazi - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Early help seeking or self-management: a quantitative assessment in the context of rheumatoid arthritis

G. Simons - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Inflammatory Arthritis

N/A

Effective prevention and management of osteoporotic fractures: a systematic literature review of non-physician health professionals’ interventions for a eular points-to-consider project

N. Wilson - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Effects of biologic dmards on physical function in patients with active psoriatic arthritis: results of network meta-analyses

A. Ruyssen-Witrand - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

Certolizumab pegol

Effects of carrageenan induced synovitis on joint damage and pain in a rat model of knee osteoarthritis

S. Ashraf - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Knee osteoarthritis

PC-515

Effects of the jak1-selective inhibitor filgotinib on gene expression profile in blood of patients with active rheumatoid arthritis

P. C. Taylor - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

Filgotinib

Efficacy and safety of ixekizumab in patients with active psoriatic arthritis: three year results from a phase 3 study (SPIRIT-P1

V. Chandran - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Psoriatic arthritis

LY2439821

Efficacy, safety and immunogenicity from week 30 to week 54 in a randomised, double-blind phase iii study comparing a proposed infliximab biosimilar (PF-06438179/GP1111 with reference infliximab

R. Alten - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Infliximab Biosimilar

Elevated ca-125 in igg4-related mesenteric disease: a red herring? a systematic literature review

I. Panayotidis - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Immunoglobulin G4 related disease

N/A

Emergence of severe spondyloarthropathy related entheseal pathology following vedolizumab therapy for inflammatory bowel disease

S. Dubash - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Inflammatory bowel disease

Entyvio

Endoplasmic reticulum stress in systemic sclerosis

S. O’reilly - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Scleroderma

N/A

Endotyping of arthritic patients using novel serological biomarkers

J.P.M. Blair - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Peritoneal colorectal carcinomatosis

N/A

Essdai domain evaluation of primary sjÖgren’s syndrome (PSS patients enrolled in two independent poc studies indicates differential utility of domains for trial inclusion and composite endpoints in pss trials

T. Dörner - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Sjogren's syndrome

Hydroxychloroquine

Eular 2018 core set of data to be collected in giant cell arteritis registries and databases viewpoints from a eular task force

L. Ehlers - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Giant cell arteritis

N/A

Eular points to consider/recommendations for the health professionals’ prevention and management of osteoporotic fractures

E. Hurkmans - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Eular recommendations for the use of imaging in mechanical low back pain

Bjarke B Hansen - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

european medicines agency's guideline on the clinical investigation of medicinal products for the treatment of rheumatoid arthritis

D. Da Silva - European League Against Rheumatism (EULAR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Rheumatoid arthritis

N/A

Copyright © 2026. QuantiNova All rights reserved